ECS Botanics (ASX: ECS) is an Australian hemp cultivator and prescription medical cannabis manufacturer — not an over-the-counter CBD oil shop. They grow sun-grown cannabis in Victoria and Tasmania, hold third-party organic certification, manufacture to pharmaceutical GMP standards, and supply their products through clinical and business-to-business channels. Their ecs botanics cbd oil products are prescription-pathway items, not OTC consumer goods. For over-the-counter hemp-derived cannabidiol oil in Byron Bay and delivered across Australia, that is a separate category — and one FraLa CBD covers from its base here in NSW.
This review is independent. FraLa CBD is a separate Australian label. Full corporate and product information for ECS Botanics is at its official consumer site.
Who is ECS Botanics?
ECS Botanics was founded in 2018 and is listed on the Australian Securities Exchange under the ticker ECS. The company has built its model around what it calls vertical integration — meaning it controls the process from seed and soil through to finished product — within the prescription medical cannabis supply chain.
Its cultivation roots are in Tasmania, where the company developed its initial industrial hemp operations. In 2021, ECS Botanics acquired Murray Meds — a licensed cultivation and manufacturing site of approximately seven acres on the Murray River in north-west Victoria. That acquisition gave the company a second growing and processing location, extending its capacity to cultivate, extract and manufacture on Australian soil.
The organic credentials matter here. ECS Botanics holds NASAA organic certification — accreditation from the National Association for Sustainable Agriculture Australia — for its cultivation practices. That means sun-grown plants, living soil management and biological inputs rather than synthetic agricultural chemicals. From a farming angle, this is the kind of approach that resonates with the ethos you see across the Northern Rivers region, where Byron Bay sits. The scale and the licensing framework are different, but the underlying commitment to soil health and organic methodology is recognisable.
Manufacturing at ECS Botanics is to PIC/S GMP standard — the Pharmaceutical Inspection Co-operation Scheme equivalent of the TGA's Good Manufacturing Practice requirements. This aligns ECS Botanics' products with international pharmaceutical production standards, which is a prerequisite for export markets and for supplying into Australia's regulated clinical channels.
The company runs two distinct consumer-facing tracks alongside its B2B pharmaceutical manufacturing: a hemp food consumer brand (retailing as ECS Botanics — hemp seeds, hemp seed oil, hemp-infused soups and protein products, distributed into Woolworths stores nationally) and its licensed medical cannabis manufacturing for the prescription supply chain. These are different parts of the business with different regulatory frameworks and different customer routes.
From field to pharmacy — vertical integration in practice
The phrase “vertically integrated” gets used loosely in the cannabis industry. For ECS Botanics, it describes a specific operational reality: the company cultivates the plant, processes the raw material, and manufactures finished pharmaceutical-grade products, all within its own licensed facilities.
The hemp food side — sold under the ECS Botanics consumer brand at ecsbotanics.com.au — represents one downstream use of industrial hemp cultivation. Hemp seed oil, hemp hearts and hemp-based soups are food products made from the seed and processed accordingly. These sit in the food regulatory framework, not the therapeutic goods framework. You can buy them at Woolworths. They do not contain meaningful cannabidiol and should not be confused with CBD oil. (For a clear breakdown of that distinction, see the FraLa CBD guide to hemp oil vs CBD oil.)
The prescription medical cannabis side is what ECS Botanics is primarily known for in ASX announcements and clinical circles. Dried cannabis flower, extracted cannabis oils, capsules, pastilles and vape products — all manufactured to PIC/S GMP for the prescription pathway. ECS Botanics operates as a B2B supplier: it does not sell prescription cannabis directly to patients. Products manufactured at its Victorian and Tasmanian facilities flow through to licensed operators, dispensaries and clinical channels.
The business signed a supply agreement with Cronos Australia and announced a $24 million offtake agreement with MediCann Health, which confirmed the scale of its B2B pharmaceutical supply position. By Nostradata's pharmaceutical data tracking, ECS Botanics ranked among Australia's top 15 medicinal cannabis brands out of more than 100 market participants, with over 800 prescribers having engaged with its product range. These are indicators of a functioning supply-chain operator in the Rx market, not a consumer retail business.
The prescription medical cannabis pathway
ECS Botanics' manufactured products enter the market through the prescription medical cannabis pathway — a specific framework regulated by the Therapeutic Goods Administration. The TGA oversees how unapproved therapeutic goods — including most medical cannabis products — are accessed in Australia.
The two main access pathways for prescription medical cannabis are the Special Access Scheme (SAS-B), under which a doctor applies to the TGA for authorisation to prescribe a specific unapproved product for an individual patient, and the Authorised Prescriber scheme, which allows approved doctors to prescribe to a class of patients without individual applications. State and territory frameworks complement these.
In practical terms: a patient speaks with a doctor, the doctor assesses and applies through the relevant TGA pathway, and if approved, the product is dispensed through a licensed pharmacy or dispensary. The patient does not browse a product page and add to cart. The prescribing process determines the product.
FraLa CBD is not a clinic, does not prescribe anything, and does not sell Schedule 4 or Schedule 8 medical cannabis products. The regulatory landscape for OTC CBD oil — including what the TGA's 2021 down-scheduling of low-dose cannabidiol changed — is covered in the FraLa CBD guide to CBD oil laws in Australia. For another perspective on how ASX-listed Australian cannabis producers sit in the prescription supply chain, see the FraLa CBD review of Cann Group.
From our CBD oil range
Pet CBD Oil 2000mg – Full Spectrum
Pet-formulated CBD oil — same hemp source as our human range, neutral MCT carrier, no human-targeted flavours or sweeteners. 2000mg in 50ml of MCT oil (40mg per ml). Best introduced under guidance from your vet.
CBG Oil 3000mg – Cannabigerol
Cannabigerol — the cannabinoid the hemp plant uses to make the others as it grows. Less abundant than CBD, which is why CBG oils sit at a different price point. 3000mg in 50ml of MCT carrier (60mg per ml).
CBD Oil 6000mg – Broad Spectrum
Broad-spectrum CBD — all the supporting cannabinoids and terpenes from the hemp plant, with THC removed. 6000mg in a 50ml MCT bottle (120mg per ml).
Hemp food vs CBD oil — clearing up the confusion
The ECS Botanics brand spans three distinct product categories that tend to get conflated: industrial hemp food, OTC hemp seed oil, and prescription medical cannabis. None of these is the same as an over-the-counter hemp-derived CBD oil purchased from an online specialist shop.
Hemp seed oil — sold by ECS Botanics via ecsbotanics.com.au and in Woolworths — is pressed from hemp seeds. It is a nutritious food oil. It does not contain significant cannabidiol. The TGA does not regulate it as a therapeutic good.
ECS Botanics medical cannabis products — the oils, dried flower and capsules manufactured to PIC/S GMP — contain cannabidiol and in some products meaningful THC. They are therapeutic goods that require a prescription. They are not available over the counter.
OTC hemp-derived CBD oil — the category FraLa CBD operates in — is extracted from the aerial parts of the hemp plant (not the seed), contains cannabidiol as the primary cannabinoid, is described by spectrum and strength, and is purchased directly online without a prescription. The TGA down-scheduled low-dose cannabidiol in 2021 to permit this category. See the FraLa CBD guide on hemp oil vs CBD oil for the full composition comparison.
Three different things. The ECS Botanics brand name spans two of them (hemp food and Rx medical cannabis); FraLa CBD operates in the third.
OTC hemp-derived CBD oil in Byron Bay — the FraLa CBD range
FraLa CBD ships hemp-derived CBD oil across Australia from Byron Bay, NSW — including to Sydney, Melbourne, Brisbane, Perth, Adelaide and Canberra. No prescription. No clinic. No wait for a TGA approval. Browse the FraLa CBD CBD oil range and order directly.
The range covers five product families, each described by composition:
Full-spectrum CBD oil — whole-plant hemp extract, full cannabinoid and terpene profile intact, a legal trace of THC (under 0.3%) confirmed per batch. MCT (coconut-derived) carrier oil. 50ml bottle.
Broad-spectrum CBD oil — the same hemp extraction with THC removed to 0%. Minor cannabinoids and terpenes retained. Same bottle, same carrier, strictly THC-free.
CBG oil — cannabigerol as the primary compound; the precursor cannabinoid the hemp plant synthesises first.
CBN oil — cannabinol isolate, THC-free. A single-cannabinoid option outside the CBD spectrum.
Pet CBD oil — full-spectrum hemp extract formulated for animals, described by composition only.
All five families are sourced from EU Labs in Amsterdam, third-party lab-tested batch by batch, with a Certificate of Analysis available on request. Prices in AUD. For buyers in South Australia, see FraLa CBD CBD oil in Adelaide; the same range ships nationally from the online shop.
Common questions about ECS Botanics and CBD oil in Byron Bay
Can I buy ECS Botanics CBD oil directly in Australia? ECS Botanics' prescription cannabis products are not sold direct to consumers. They are supplied through licensed operators and clinical dispensing channels, accessed via a doctor's prescription under the TGA's medical cannabis pathways. The hemp food products — hemp seed oil, hemp hearts, soups — are available at ecsbotanics.com.au and at Woolworths stores.
Does ECS Botanics grow hemp in Australia? Yes. ECS Botanics cultivates cannabis at its facilities in north-west Victoria (Murray Meds, Murray River) and Tasmania. It holds NASAA organic certification for its cultivation practices and grows sun-grown plants using living soil and biological inputs, under TGA and state licensing frameworks for medicinal cannabis.
What is the difference between ECS Botanics medical cannabis and OTC CBD oil from FraLa CBD? ECS Botanics manufactures prescription medical cannabis products — accessed via a doctor's prescription, dispensed through licensed pharmacies. FraLa CBD sells OTC hemp-derived CBD oil: five families described by cannabinoid composition, no prescription required, ordered online and shipped across Australia including to Byron Bay, Sydney, Melbourne and Adelaide. Different companies, different regulatory frameworks, different purchase processes.
Is ECS Botanics publicly listed on the ASX? Yes. ECS Botanics Holdings Ltd trades on the Australian Securities Exchange under the ticker ASX: ECS. Investor and corporate information is available through the ASX and on the corporate site. The consumer product range — hemp food and wellness products — is at ecsbotanics.com.au.
ECS Botanics operates at the cultivation and pharmaceutical manufacturing end of the Australian cannabis landscape. FraLa CBD operates at the OTC consumer end. Both are part of a broader hemp and cannabis industry in Australia, but the products, the regulations and the purchase process are different in every respect. If you want to research ECS Botanics' operations, start at their official site. For over-the-counter hemp-derived cannabidiol oil from Byron Bay — five families, lab-tested, ships nationally — browse the FraLa CBD range.
